This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Email citation

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2019 Sep 10;322(10):921-922.

doi: 10.1001/jama.2019.11419.

Accelerating the Science of SCD Therapies-Is a Cure Possible?

Edward J Benz Jr¹, Traci Heath Mondoro², Gary H Gibbons²

Affiliations

Affiliations

¹ Dana-Farber Cancer Institute, Boston, Massachusetts.
² National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

PMID: 31393519
DOI: 10.1001/jama.2019.11419

Accelerating the Science of SCD Therapies-Is a Cure Possible?

Edward J Benz Jr et al. JAMA. 2019.

. 2019 Sep 10;322(10):921-922.

doi: 10.1001/jama.2019.11419.

Authors

Edward J Benz Jr¹, Traci Heath Mondoro², Gary H Gibbons²

Affiliations

¹ Dana-Farber Cancer Institute, Boston, Massachusetts.
² National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.

PMID: 31393519
DOI: 10.1001/jama.2019.11419

No abstract available

PubMed Disclaimer

Similar articles

A cure for murine sickle cell disease through stable mixed chimerism and tolerance induction after nonmyeloablative conditioning and major histocompatibility complex-mismatched bone marrow transplantation.
Kean LS, Durham MM, Adams AB, Hsu LL, Perry JR, Dillehay D, Pearson TC, Waller EK, Larsen CP, Archer DR. Kean LS, et al. Blood. 2002 Mar 1;99(5):1840-9. doi: 10.1182/blood.v99.5.1840. Blood. 2002. PMID: 11861303
Pediatric patients with sickle cell disease: use of complementary and alternative therapies.
Sibinga EM, Shindell DL, Casella JF, Duggan AK, Wilson MH. Sibinga EM, et al. J Altern Complement Med. 2006 Apr;12(3):291-8. doi: 10.1089/acm.2006.12.291. J Altern Complement Med. 2006. PMID: 16646728
Spondylocheirodysplastic Ehlers-Danlos syndrome (SCD-EDS) and the mutant zinc transporter ZIP13.
Bin BH, Hojyo S, Ryong Lee T, Fukada T. Bin BH, et al. Rare Dis. 2014 Dec 1;2(1):e974982. doi: 10.4161/21675511.2014.974982. eCollection 2014. Rare Dis. 2014. PMID: 26942106 Free PMC article.
Sickle cell disease: current activities, public health implications, and future directions.
Creary M, Williamson D, Kulkarni R. Creary M, et al. J Womens Health (Larchmt). 2007 Jun;16(5):575-82. doi: 10.1089/jwh.2007.CDC4. J Womens Health (Larchmt). 2007. PMID: 17627395 Review.
Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
Talano JA, Cairo MS. Talano JA, et al. Eur J Haematol. 2015 May;94(5):391-9. doi: 10.1111/ejh.12447. Epub 2014 Oct 10. Eur J Haematol. 2015. PMID: 25200500 Review.

See all similar articles

Cited by

Motivations and Decision-Making of Adult Sickle Cell Patients in High-Risk Clinical Research.
Cho HL, Kim SYH, Fitzhugh C, Hsieh M, Tisdale J, Grady C. Cho HL, et al. Biol Blood Marrow Transplant. 2020 Jun;26(6):1225-1232. doi: 10.1016/j.bbmt.2020.03.014. Epub 2020 Mar 19. Biol Blood Marrow Transplant. 2020. PMID: 32200120 Free PMC article.
The molecular basis for the prothrombotic state in sickle cell disease.
Shet AS, Lizarralde-Iragorri MA, Naik RP. Shet AS, et al. Haematologica. 2020 Oct 1;105(10):2368-2379. doi: 10.3324/haematol.2019.239350. Haematologica. 2020. PMID: 33054077 Free PMC article.
Reply to R. Meisel.
Eapen M, Brazaukas R. Eapen M, et al. J Clin Oncol. 2023 Jun 10;41(17):3273-3274. doi: 10.1200/JCO.23.00508. Epub 2023 Apr 12. J Clin Oncol. 2023. PMID: 37043706 Free PMC article. No abstract available.
5-(Hydroxymethyl)furfural restores low-oxygen rheology of sickle trait blood in vitro.
Hansen S, Wood DK, Higgins JM. Hansen S, et al. Br J Haematol. 2020 Mar;188(6):985-993. doi: 10.1111/bjh.16251. Epub 2019 Dec 30. Br J Haematol. 2020. PMID: 31889311 Free PMC article.
Process and strategies for patient engagement and outreach in the Sickle Cell Disease (SCD) community to promote clinical trial participation.
Byrnes C, Botello-Harbaum M, Clemons T, Bailey L, Valdes KM, Coleman-Cowger VH. Byrnes C, et al. J Natl Med Assoc. 2022 Apr;114(2):211-217. doi: 10.1016/j.jnma.2022.01.003. Epub 2022 Jan 31. J Natl Med Assoc. 2022. PMID: 35093266 Free PMC article.

LinkOut - more resources

Full Text Sources
- Ovid Technologies, Inc.
- Silverchair Information Systems